2021 Americas Sample Management Hybrid Symposium
Sample management is the bedrock of every phase of chemical and biological discovery. The past year has tested both academic and industrial programs and even in the best of times, there’s room for improvement in our processes. This year’s program will focus on best practices, lessons learned and new trends in sample management with an emphasis on the impact and potential of emerging technologies and applications of automation. We will also address the business of sample management as it pertains to mergers and acquisitions, the pros and cons of outsourcing and growing challenges in our supply chain. The SLAS 2021 Americas Sample Management Symposium welcomes all compound and sample management professionals – both in the lab and in leadership – to obtain fresh perspectives and share innovative solutions to challenges in these domains.
Bristol Myers Squibb
Research Operations Senior Manager
Manager, Compounds Australia
Ms Moana Simpson is the Manager of Compounds Australia, and has over 20 years’ experience in providing support for drug discovery research within Australia and the UK, both in academia and in the pharmaceutical industry. Ms Simpson was instrumental in the initial development and subsequent growth of Compounds Australia from its inception to now a fully operational and busy compound management facility. Ms Simpson holds a Bachelor of Science with Honours and a Graduate Diploma in Project Management; her expertise is primarily in the areas of chemistry and biochemistry.
Vice President Sample Management Technology
Michael Jobling, Ph.D.
Vice President, Sample Management
Patrick Faloon, Ph.D.
Travis Mathewson, Ph.D.
Senior Principal Scientist
Lane Milde, Ph.D.
Steve McCoy, Ph.D.
Head of Sales
Susana A. Morais, Ph.D.
Assoc. Prin Scientist
Merck & Co., Inc.
Christian Ferrante, Ph.D.
Scientific Associate Director
Bristol Myers Squibb
Brenda Li-Johnson, Ph.D.
Screening Profiling and Mechanistic Biology - Sample Management UP Group Leader
Marianne K. Henderson, M.S., C.P.C.
Center for Global Health/National Cancer Institute/NIH/DHHS
Executive Director, Discovery Sample Management
Marybeth Burton leads MSD’s global Discovery Sample Management group based in the US at the Rahway, New Jersey site. She is responsible for small molecule compound management, chemical inventory management and compliance, and chemistry operations. Her group monitors compound collection quality and participates in efforts to continuously improve both stewardship and composition of MSD's small molecule compound collection. Marybeth also has responsibility for management of discovery biological samples within MSD and has collaborated with colleagues in clinical research to develop an overall bio-repository strategy. Marybeth has been involved with process optimization efforts and development of new workflows to support changing sample management needs resulting from globalization of drug discovery efforts. Her team is also currently responsible for managing external chemistry partner relationships and establishing global compound logistics workflows.
Prior to her tenure at MSD, Marybeth led the compound management group at Schering-Plough. Marybeth holds a B.A. in Biology and an M.S. in Information Science.
David Hayes, Ph.D.
Director, North American Operations
Heather Colvan, Ph.D.
Director of Operations
Heather Colvan is the cofounder and Director of Operations for Simplicis. Simplicis provides expert sample management solutions focused on data and hardware integration for automated pharmaceutical laboratories.
For the past 12 years Heather has been focused on delivering problem specific solutions to Simplicis's clients with a dedication to data management. Prior to Simplicis Heather worked in healthcare revenue cycle management implementing and integrating claims inventory management solutions.
Heather is an advocate for women in computer science and gladly volunteers her time to facilitate a Girls Who Code club at her son's school.